Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC trimmed its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 12.8% during the third quarter, HoldingsChannel reports. The fund owned 4,045,573 shares of the company’s stock after selling 596,491 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Option Care Health were worth $126,626,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Option Care Health by 84.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 70,119 shares of the company’s stock worth $2,195,000 after acquiring an additional 32,142 shares during the last quarter. FORA Capital LLC acquired a new stake in shares of Option Care Health in the 3rd quarter worth approximately $1,178,000. CreativeOne Wealth LLC boosted its holdings in shares of Option Care Health by 21.9% in the third quarter. CreativeOne Wealth LLC now owns 14,380 shares of the company’s stock valued at $450,000 after acquiring an additional 2,585 shares in the last quarter. Townsquare Capital LLC increased its stake in shares of Option Care Health by 6.2% during the third quarter. Townsquare Capital LLC now owns 72,675 shares of the company’s stock valued at $2,275,000 after acquiring an additional 4,258 shares during the period. Finally, Advantage Alpha Capital Partners LP bought a new stake in Option Care Health during the third quarter worth approximately $2,974,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on OPCH. JMP Securities raised their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Barrington Research decreased their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research report on Thursday, October 31st. Truist Financial decreased their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and cut their price objective for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Trading Up 0.2 %

Shares of NASDAQ OPCH opened at $23.80 on Monday. The business has a 50-day moving average price of $26.84 and a two-hundred day moving average price of $28.87. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $4.05 billion, a PE ratio of 20.00, a PEG ratio of 2.46 and a beta of 1.32. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the stock in a transaction on Friday, November 8th. The shares were purchased at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.